Moglia Stephen A. 4
4 · Orexigen Therapeutics, Inc. · Filed Mar 16, 2018
Insider Transaction Report
Form 4
Moglia Stephen A.
VP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2018-03-15$0.24/sh−1,694$407→ 0 total
4 · Orexigen Therapeutics, Inc. · Filed Mar 16, 2018
Common Stock